Meridian Bioscience Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-4.04 .
The company employs approximately 560 people and operates in the Health sector, within the Medical Supplies and Equipment industry.
Over the past 12 months, Meridian Bioscience Inc. reported $122.58 Millions in revenue, generating net income of $-24.12 Millions.
Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.
The company trades under the ticker VIVO.